Tailored HER2 ECD mRNA-LNP vaccines boost CD8+ T cell-mediated antitumor immunity for HER2-positive tumor suppression

Drug Resistance Updates · Published 2026-06-26 · DOI 10.1016/j.drup.2026.101439

Authors (14)

Kexin Li, Zilin Ma, Xiaoya Li, Xiuping Chi, Ying Zhang, Cong Zhang, Wen Li, Mingyu Cui, Wei Qi, Yating Zhao, Jun Wang, Guogui Sun, Hongtao Zhang, Lianmei Zhao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Li, K., Ma, Z., Li, X., et al. (2026). Tailored HER2 ECD mRNA-LNP vaccines boost CD8+ T cell-mediated antitumor immunity for HER2-positive tumor suppression. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101439

Related articles

• Resistance to CAR-based cell therapy: Mechanisms and overcoming strategies · Drug Resistance Updates · 2026 · Same journal
• Low dose radiation induces new protein synthesis that promotes cancer radiotherapy resistance · Drug Resistance Updates · 2026 · Same journal
• Long-term outcomes and exploratory analysis from a randomized phase 3 trial of radiation dose escalation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma · Drug Resistance Updates · 2026 · Same journal
• ZBED6-Driven Nucleotide Metabolic Reprogramming Improves Sensitivity to anti-PD1 Therapy in NK/T Cell Lymphoma · Drug Resistance Updates · 2026 · Same journal
• PRKCA and ABCB1 dual-enriched exosomes are key drivers of drug resistance in chronic myeloid leukemia · Drug Resistance Updates · 2026 · Same journal
• Mechanistic analysis on epigenetic programming of tumor drug resistance · Drug Resistance Updates · 2026 · Same journal
• NHE6-driven endosome-autophagy axis confers proteasome inhibitor resistance in multiple myeloma · Drug Resistance Updates · 2026 · Same journal
• Resensitizing drug-resistant cancers by co-targeting apoptosis and mitochondrial stress pathway · Drug Resistance Updates · 2026 · Same journal
• Targeting hyaluronan synthesis sensitizes anti-PD1 immunotherapy in cancer · Drug Resistance Updates · 2026 · Same journal
• Immunotherapy in Cancer: Mechanisms and Strategies to Overcome Resistance · Drug Resistance Updates · 2026 · Same journal